ClinicalTrials.Veeva

Menu

Does Size Matter: A Single Case Experimental Design of Limiting the Depth of Penetration During Intercourse

K

King's College London

Status

Completed

Conditions

Peyronie Disease

Treatments

Device: Penile Ring

Study type

Interventional

Funder types

Other

Identifiers

NCT04052217
HR-16/17-2018

Details and patient eligibility

About

Our hypothesis is that reducing the length of the penis does not lead to loss of sexual satisfaction or emotional closeness in the female partner. This will be investigated by a single case experimental design in 12 couples.

Full description

The investigators will conduct a single case experimental design (SCED), in which a woman acts as her own control with a reversal design between randomly allocated phases. These include a control phase (A) and phases with various sizes of penile rings (B, C, and D).

The male participant will be asked to measure the length and girth of their erect penis using standardized instructions and flexible tape measure before the start of the experiment. This will partly determine the inner circumference of the ring provided. The male participant will be given instructions on how to use the penile rings and ensure that the female participant is blind to the size of the ring used.

There will be randomization (a) to the phase (the size of ring) and (b) the number of times of intercourse within a phase. The male partner will be blind to ratings made by the female partner. There is no carry over effect from one phase to another. The randomization of the phase means less guessing of the size of the ring, and less interaction with moderators (e.g. menstrual cycle, alcohol, holiday or life events randomly spread across phases). In a SCED, one then replicates in Case 2, Case 3 etc and a meta-analysis is conducted of all the single cases.

Randomisation will occur to either

  1. Phase A "Normal" intercourse with very thin (less than 0.5cm) ring randomised to either 3, 4 or 5 episodes of intercourse)
  2. Phase B - 1" ring randomised to either 3, 4, or 5 episodes of intercourse)
  3. Phase C - 1.5" ring randomised to either 3, 4, or 5 episodes of intercourse)
  4. Phase D - 2" ring randomised to either 3, 4, or 5 episodes of intercourse) The male partner will be kept informed by text or email or phone (whichever is convenient) of when to change the size of ring and the number of times it should be used. The female partner will be asked to be blind to the size of ring used after each episode of intercourse. Blindness will be tested by asking if the female partner "saw" the size of the ring or whether she was able to guess when a change in the size of the ring occurred.

Measures:

The investigators will use a Visual Analogue Scale (0-100) for the female participant ratings of (a) sexual pleasure and (b) how emotionally connected she felt to her partner (c) any adverse experiences.

The female participant will be asked to rate the degree of change (positive or negative) that would be significant for them e.g. a drop of rating 65 to 45) The female participant will be asked to rate satisfaction and emotional closeness as soon as possible after intercourse. The investigators will ask all participants to enter the data directly onto web based capture of data. This will be anonymized so that they will be identified by a character.

The male participant will be asked to confirm the size of the ring used and any other comments.

Enrollment

12 patients

Sex

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Heterosexual couples in a stable relationship (defined as 6 months or more)
  2. Having regular intercourse (defined as on average twice a week).

Exclusion criteria

  1. Any current sexual dysfunction in either partner
  2. Any current emotional disorder in either partner
  3. Men with a micro-penis

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

12 participants in 4 patient groups

Control Ring
Other group
Description:
"Normal" intercourse with very thin (less than 0.5cm) ring randomised to either 3, 4 or 5 episodes of intercourse (Phase A)
Treatment:
Device: Penile Ring
1" RIng
Experimental group
Description:
Intercourse wearing a 1" ring. Randomised to either 3, 4, or 5 episodes of intercourse (Phase B)
Treatment:
Device: Penile Ring
1.5" Ring
Experimental group
Description:
Intercourse wearing a 1.5" ring randomised to either 3, 4, or 5 episodes of intercourse (Phase C)
Treatment:
Device: Penile Ring
2" Ring
Experimental group
Description:
Intercourse with a 2" ring randomised to either 3, 4, or 5 episodes of intercourse (Phase D)
Treatment:
Device: Penile Ring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems